Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing?

BACKGROUND AND OBJECTIVE: Low-molecular-weight heparins are routinely administered to patients in the intensive care unit to prevent venous thromboembolisms. There is considerable evidence that low-molecular-weight heparin doses should be personalised based on anti-Xa levels, but pharmacokinetic dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Diepstraten, Jeroen, van Rongen, Anne, Zijlstra, Marianne P., Kruip, Marieke J. H. A., van der Heiden, Pim L. J., ter Heine, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800240/
https://www.ncbi.nlm.nih.gov/pubmed/36581732
http://dx.doi.org/10.1007/s40262-022-01202-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800240/
https://www.ncbi.nlm.nih.gov/pubmed/36581732
http://dx.doi.org/10.1007/s40262-022-01202-6

Ejemplares similares